NEW YORK, NY, FADEL, innovator of enterprise rights and royalty management software, announced it has completed its Series B venture funding round. Read More
KALAMAZOO, MI, Ablative Solutions, a company pioneering new approaches for the treatment of hypertension, today announced the first close of its $77 million Series D funding round. Read More
SEATTLE, WA, Immusoft, a cell therapy company, announced today it has held the final closing in its $20 million oversubscribed Series B financing. Read More